Cancer incidence in egypt: results of the national population-based cancer registry program

Amal S Ibrahim, Hussein M Khaled, Nabiel Nh Mikhail, Hoda Baraka, Hossam Kamel, Amal S Ibrahim, Hussein M Khaled, Nabiel Nh Mikhail, Hoda Baraka, Hossam Kamel

Abstract

Background. This paper aims to present cancer incidence rates at national and regional level of Egypt, based upon results of National Cancer Registry Program (NCRP). Methods. NCRP stratified Egypt into 3 geographical strata: lower, middle, and upper. One governorate represented each region. Abstractors collected data from medical records of cancer centers, national tertiary care institutions, Health Insurance Organization, Government-Subsidized Treatment Program, and death records. Data entry was online. Incidence rates were calculated at a regional and a national level. Future projection up to 2050 was also calculated. Results. Age-standardized incidence rates per 100,000 were 166.6 (both sexes), 175.9 (males), and 157.0 (females). Commonest sites were liver (23.8%), breast (15.4%), and bladder (6.9%) (both sexes): liver (33.6%) and bladder (10.7%) among men, and breast (32.0%) and liver (13.5%) among women. By 2050, a 3-fold increase in incident cancer relative to 2013 was estimated. Conclusion. These data are the only available cancer rates at national and regional levels of Egypt. The pattern of cancer indicated the increased burden of liver cancer. Breast cancer occupied the second rank. Study of rates of individual sites of cancer might help in giving clues for preventive programs.

Figures

Figure 1
Figure 1
Map of Egypt showing the location of the 5 peripheral registries of the national network of population-based cancer registries National Cancer Institute, Cairo, and South Egypt Cancer Institute, Assiut.
Figure 2
Figure 2
The NCRP Web Based System (3-Tier Architecture).
Figure 3
Figure 3
Calculated age specific incidence rates for Egypt 2008–2011.
Figure 4
Figure 4
Calculated age specific incidence rates for liver cancer in Egypt 2008–2011.
Figure 5
Figure 5
Calculated age specific incidence rates for breast cancer in Egypt 2008–2011.
Figure 6
Figure 6
Calculated age specific incidence rates for urinary bladder cancer in Egypt 2008–2011.
Figure 7
Figure 7
Estimated number of cases in Egypt (2013–2050).
Figure 8
Figure 8
Estimated number of cases in Egypt (2013–2050) and causes of the increase in cases.

References

    1. Dolbey R, Mooro AW. The incidence of cancer in Egypt: an analysis of 671 cases. The Lancet. 1924;203(5247):587–590.
    1. Bedwani R, El-Khwsky F, Reganathan E, et al. Epidemiology of bladder cancers in Alexandria, Egypt: tobacco smoking. International Journal of Cancer. 1997;73:64–67.
    1. Abou-Zeid W, El-Khwsky F, Mokhtar S, Sherif M, Mahdy N. Descriptive epidemiology and multivariate survival analysis of oral and pharyngeal malignancies in Alexandria. Journal of the Medical Research Institute. 2006;27(4):262–270.
    1. El-Attar I. Cancer statistics, NCI, 2004. Cairo, Egypt: Department of Biostatics and Epidemiology, NCI; 2005. .
    1. Sherif M, Ibrahim AS. The Profile of Cancer in Egypt. Cairo University, The National Cancer Institute, The Cancer Registry for the Metropolitan Cairo Area (CRMCA); 1987.
    1. Young JL. The hospital-based cancer registry. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, editors. Cancer Registration: Principles and Methods. 1991. (IARC Scientific Publications No. 05).
    1. Silava I. Chapter 17: The Role of Cancer Registries. Geneva, Switzerland: International Agency for Research on Cancer, World Health Organization; 1999. Cancer epidemiology: principles and methods; pp. 385–403.
    1. Ibrahim AS, Hussein H, Ismail K, Hablas A, Abdel Bar I, Ramadan M. Cancer Profile in Gharbiah—Egypt, Methodology and Results, 1999. Cairo, Egypt: Gharbiah Population-Based Cancer Registry (GPCR); 2003.
    1. Ibrahim AS, Seif-Eldein IA, Ismail K, et al. Triennial Report of 2000–2002, Gharbiah Population-Based Cancer Registry. Cairo, Egypt: Middle East Cancer Consortium; 2007. Cancer in Egypt, Gharbiah.
    1. Curado MP, Edwards B, Shir HR, et al., editors. Cancer Incidence in Five Continents. Vol. 9. Lyon, France: IARC; 2007. (IARC Scientific Publication, no. 160).
    1. Curado MP, Edwards B, Shir HR, et al., editors. Cancer Incidence in Five Continents, Vol. X. Lyon, France: IARC Press; 2013. .
    1. Hirko KA, Soliman AS, Hablas A, et al. Trends in breast cancer incidence rates by age and stage at diagnosis in gharbiah, Egypt, over 10 years (1999–2008) Journal of Cancer Epidemiology. 2013;2013:7 pages.916394
    1. Zeeneldin AA, Ramadan M, Gaber AA, Taha FM. Clinico-pathological features of breast carcinoma in elderly Egyptian patients: a comparison with the non-elderly using population-based data. Journal of the Egyptian National Cancer Institute. 2013;25(1):5–11.
    1. Dey S, Soliman AS, Hablas A, et al. Urban-rural differences in breast cancer incidence in Egypt (1999–2006) Breast. 2010;19(5):417–423.
    1. Soliman AS, Banerjee M, Lo A-C, et al. High proportion of inflammatory breast cancer in the population-based cancer registry of gharbiah, Egypt. Breast Journal. 2009;15(4):432–434.
    1. Zeeneldin AA, Saber MM, El-Din IAS, Frag SA. Small intestinal cancers among adults in an Egyptian district: a clinicopathological study using a population-based cancer registry. Journal of the Egyptian National Cancer Institute. 2013;25(3):107–114.
    1. Saber MM, Zeeneldin AA, Samra MA, Farag SA. Primary gastrointestinal lymphoma in an Egyptian district: a study using a population-based cancer registry. The Journal of the Egyptian National Cancer Institute. 2013;25(2):95–101.
    1. Veruttipong D, Soliman AS, Gilbert SF, et al. Age distribution, polyps and rectal cancer in the egyptian population-based cancer registry. World Journal of Gastroenterology. 2012;18(30):3997–4003.
    1. Herzog CM, Dey S, Hablas A, et al. Geographic distribution of hematopoietic cancers in the nile delta of Egypt. Annals of Oncology. 2012;23(10):2748–2755.
    1. Fedewa SA, Soliman AS, Ismail K, et al. Incidence analyses of bladder cancer in the Nile delta region of Egypt. Cancer Epidemiology. 2009;33(3-4):176–181.
    1. Dey S, Hablas A, Seifeldin IA, et al. Urban-rural differences of gynaecological malignancies in Egypt (1999–2002) BJOG. 2010;117(3):348–355.
    1. National Cancer Registry Program of Egypt. .
    1. DEPedits©. Conversion and Check Programs for Cancer Registries software. .
    1. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology. 3rd edition. World Health Organization; 2000.
    1. Standardized Incidence Ratio and Confidence Limits. .
    1. Central Agency for Public Mobilization and Statistics (CAPMAS),
    1. SEER Program Self Instructional Manual for Cancer Registries. Book 1: Objectives and Functions of Cancer Registries. SEER Program; 1999. edited by E. M. Shambaugh, M. A. Weiss , A. Fritz , M. Hurst, C. H. Johnson, M. A. Kruse, and J. Seiffert.
    1. IARC. Cancer Registration: Principles and Methods. Vol. 95. Lyon, France: International Agency for Research on Cancer; 1991. (IARC Scientific Publication). O. M. Jensen , D. M. Parkin , R. MacLennan , C. S. Muir and R. Skeet, eds.
    1. List of SEER Registries, .
    1. Eser S, Yakut C, Özdemir R, et al. Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pacific Journal of Cancer Prevention. 2010;11(6):1731–1739.
    1. Ibrahim AS, Mikhail NNH, editors. Egypt National Cancer Registry: Aswan Profile—2008. National Cancer Registry Program of Egypt; 2010. (Publication Number RR1).
    1. Zeng H, Zheng R, Zhang S, Zou X, Chen W. Female breast cancer statistics of 2010 in China: estimates based on data from 145 population-based cancer registries. Journal of Thoracic Disease. 2014;6(5):466–470.
    1. Ferlay J, Soerjomataram I, Ervik M, et al. Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. 1.0. Lyon, France: International Agency for Research on Cancer; 2010. (IARC CancerBase no. 11). .
    1. Ezzat S, Abdel-Hamid M, Abdel-Latif Eissa S, et al. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. International Journal of Hygiene and Environmental Health. 2005;208(5):329–339.
    1. Abdel-Hamid M, El-Daly M, Molnegren V, et al. Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. Journal of General Virology. 2007;88(5):1526–1531.
    1. Cowgill KD, Loffredo CA, Eissa SA-L, et al. Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt. International Journal of Epidemiology. 2004;33(5):1034–1039.
    1. Farawela H, Khorshied M, Shaheen I, et al. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin's lymphoma risk in Egypt. Infection, Genetics and Evolution. 2012;12(6):1189–1194.
    1. Ibrahim AS, Mikhail NNH, Khaled H, et al. Cancer incidence in Egypt: a closer look to registry results. In press.
    1. Boyle P, Levin B, editors. World Cancer Report 2008. Lyon, France: IARC; 2008.
    1. Bray F, Znaor A, Cueva P, et al. Planning and Developing Population-based Cancer Registration in Low- and Middle-Income Settings. IARC; 2014.
    1. United States Census Bureau. International Data Base, .

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera